Effects of Sacubitril/Valsartan on cardiovascular biomarkers in chronic heart failure patients

Conclusion The results showed that while sacubitril/valsartan decreased sNEP activity without no effect on the mNEP release. The increase in T71 proBNP glycosylation being responsible for the discrepancies between BNP and NT-proBNP plasma levels.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research